简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-12-04 10:07 Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics
2024-12-02 12:56 GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
2024-11-28 14:04 Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis
2024-11-28 11:42 U.S. FDA Approves AOP Health’s RapiblykTM (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting
2024-11-27 11:27 Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs
2024-11-26 16:22 Kolmar BNH Revolutionizes ESG with HemoHIM, an Eco-friendly Health Supplement
2024-11-25 11:39 TA Announces Strategic Investment in Vee Healthtek to Support Continued Growth and Innovation
2024-11-25 11:00 Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape
2024-11-22 15:12 Rigaku BioScience Lab Opens in USA
2024-11-22 11:11 Pacific Prime Unveils Cost of International Health Insurance Report 2024
2024-11-21 13:55 NationsBenefits® Expands Grocery Access to United Supermarkets
2024-11-21 10:20 Novotech Releases Report on Global Bladder Cancer Clinical Trials, Offering Insights for Oncology Advancement
2024-11-21 10:11 SBC Medical Launches SBC Wellness, a New Solution to Help Companies Deliver Additional Health Benefits and Enhance Employee Wellbeing
2024-11-20 16:30 Pharmanovia Signs Novel Biologic In-Licensing Agreement With Lindis Biotech to Commercialise Catumaxomab for Treatment of Rare Condition, Malignant Ascites
2024-11-20 10:22 NationsBenefits Acquires Good Measures to Revolutionize Food as Medicine Solutions
2024-11-19 11:36 HistoSonics® Enrolls First Patients in Company’s Novel BOOMBOX Master Study
2024-11-19 10:12 Novotech Releases Comprehensive Report on the Global Clinical Trial Landscape for Small Cell Lung Cancer (SCLC)
2024-11-18 11:15 BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates
2024-11-18 11:11 BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer
2024-11-18 10:14 The Future of Diffuse Large B-Cell Lymphoma (DLBCL) Treatment: Insights from Global Research

Business Wire Weibo

Press Releases

Latest Releases